Efficacy and Tolerability of Semaglutide in Patients With Type-2 Diabetes Mellitus: Experience of a Tertiary Care Hospital, Pakistan
Background: Semaglutide, a Glucagon-like peptide 1 (GLP-1) is highly effective as an anti-diabetic medication along with additional benefits of significant reduction in cardiovascular events and weight. Objectives: There is a lack of reliable evidence confirming the benefits of Semaglutide in the Pa...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2023-11-01
|
| Col·lecció: | Clinical Medicine Insights: Endocrinology and Diabetes |
| Accés en línia: | https://doi.org/10.1177/11795514231213568 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|